Quinoxaline chemistry. Part 14. 4-(2-Quinoxalylamino)-phenylacetates and 4-(2-quinoxalylamino)-phenylacetyl-L-glutamates as analogues-homologues of classical antifolate agents. Synthesis and evaluation of in vitro anticancer activity

Farmaco

Volumn 57, Issue 1, 2002, Pages 1-8

  Piras, Sandra ^a   Loriga, Mario ^a   Paglietti, Giuseppe ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

(Quinoxalylamino) phenylacetates and (quinoxalylamino) phenylacetyl L glutamate; Anticancer activity; Quinoxalines derivatives

Indexed keywords

ANTINEOPLASTIC AGENT; FOLIC ACID ANTAGONIST; QUINOXALINE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER CENTER; CANCER INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG SCREENING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY;

ANTINEOPLASTIC AGENTS; FOLIC ACID ANTAGONISTS; HUMANS; PHENYLACETATES; QUINOXALINES; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0036165776     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(01)01159-4     Document Type: Article

References (13)

1. Quinoxaline chemistry: Part 4. 2-(R)-Anilinoquinoxalines as non classic antifolate agents. Synthesis, structure elucidation and evaluation of in vitro anticancer activity
2. Quinoxaline chemistry. Part 5. 2-(R)-Benzylaminoquinoxalines as non classical antifolate agents. Synthesis and evaluation of in vitro anticancer activity
3. Quinoxaline chemistry. Part 7. 2-[Aminobenzoates]- and 2[aminobenzoylglutamate]-quinoxalines as classical antifolate agents. Synthesis and evaluation of in vitro anticancer, anti-HIV and antifungal activity
4. Quinoxaline chemistry. Part 8. 2-[Anilino]-3-[carboxy]-6(7)-substituted quinoxalines as non classical antifolate agents. Synthesis and evaluation of in vitro anticancer, anti-HIV and antifungal activity
5. Quinoxaline chemistry. Part 9. Quinoxaline analogues of TMQ and 10-propargyl-5,8-dideaza folic acid and its precursors. Synthesis and evaluation of in vitro anticancer activity
6. Quinoxaline chemistry. Part 10. Quinoxaline 10-oxa analogues of TMQ and 10-propargyl-5,8-dideaza folic acid and its precursors. Synthesis and evaluation of in vitro anticancer activity
7. Quinoxaline chemistry. Part 11. 3-Phenyl-2(phenoxy-and phenoxymethyl)-6(7) or 6,8-substituted quinoxalines and N-[4-(6(7)-substituted or 6,8-disubstituted-3-phenylquinoxalin-2-yl)hydroxy or hydroxymethyl]benzoylglutamates. Synthesis and evaluation of in vitro anticancer activity and enzymatic inhibitory activity against dihydrofolate reductase and thymidylate synthase
8. Quinoxaline chemistry. Part 12. 3-Carboxy-2[phenoxy]-6(7)substituted quinoxalines and N-[4-(6(7) substituted-3-carboxyquinoxaline-2-yl)hydroxy] benzoylglutamates. Synthesis and evaluation of in vitro anticancer activity
9. Quinoxaline chemistry. Part 13. 3-Carboxy-2-benzylamino-substituted quinoxalines and N-[4[(3-carboxyquinoxalin-2-yl)aminomethyl]benzoyl]-L-glutamates: Synthesis and evaluation of in vitro anticancer activity
10. Synthesis of 2-monosubstituted and 2,3-disubstituted quinoxalines
11. Quinoxalines derivatives. IX. An unusual chlorine substitution in quinoxalines N-oxides. Its scope and limitations
12. Synthesis and excitatory amino acid pharmacology of a series of heterocyclic-fused quinoxalinones and quinazolinones
13. Status of the NCI preclinical antitumor drug discovery screen